Wisp Launches Comprehensive Weight Care Vertical to Support Women Struggling with Hormonal Imbalances

The Company Also Bolsters its Menopause Solutions, Empowering Women Through All Major Stages of Their Healthcare Journey

Wisp, the largest pure play women's telehealth company in the U.S. focused on providing sexual and reproductive health solutions, now serving more than 1.2 million patients, today announced a significant expansion of its services with the introduction of its weight care vertical. Wisp will provide women with personalized, online healthcare consultations, offering four products, including GLP-1s, to help women struggling with hormonal imbalances due to conditions like perimenopause and menopause, Polycystic Ovary Syndrome (PCOS), and endometriosis. With this launch, the company debuts its first-ever exclusive over-the-counter weight care capsules, designed to promote women's metabolic health.

“Wisp is committed to providing sustainable support for women’s weight loss journeys, addressing a critical yet overlooked aspect of women’s health,” said Monica Cepak, CEO of Wisp. “As the dialogue around obesity evolves, we recognize that underlying conditions — especially hormonal imbalances linked to perimenopause and menopause — remain under-researched, underdiagnosed, and undertreated. With these new offerings, we’re proud to continue expanding access to comprehensive care, offering tailored solutions for every woman and every condition at every price point.”

Beginning today, patients can request prescription GLP-1 medications and over-the-counter supplements via pharmacy pickup or free discreet delivery. The process starts with a digital health consultation on Wisp’s platform, which a licensed medical provider then reviews, and if deemed safe and suitable, patients can begin the program. In addition to educational content and monthly check-ins, Wisp’s weight care program includes the following options:

• Semaglutide (Branded FDA-Approved Wegovy®) Subcutaneous Injectable Medication
• Compounded Semaglutide Subcutaneous Injectable Medication
• Compounded Sublingual Semaglutide
• Metabolic Support & GLP-1 Boost Capsules
  • Key Ingredients Include:
    • Eriomin ®: Eriomin may increase GLP-1 levels, support insulin function, and promote healthy blood glucose levels in the normal range.
    • Actiz!ng(™) (Black Ginger Extract): Clinically-tested to help promote the reduction of abdominal fat, and has been shown to significantly increase calorie burning.
    • Glucovantage ® Dihydroberberine (Berberine): Five times more bioavailable than berberine, GlucoVantage may support a healthier body composition and lower blood sugar levels.
    • PoZibio(™) (Lactobacillus paracasei): May decrease gut inflammation and support healthy aging and metabolic function.

In tandem, Wisp expands its menopause solutions with offerings tailored to support the more than 2 million women who experience menopause each year. Seeing the potential to improve treatments and access, as menopause remains the female health condition with the highest unmet needs, Wisp is enhancing its perimenopause and menopause offerings with new prescription Estriol Face Cream as well as new hormone replacement therapy treatments: Transdermal Estradiol Patches, Oral Micronized Progesterone Capsules, and Oral Provera Tablets.

Wisp’s move into weight management is part of its broader vision to support women at every stage of life. The brand plans to broaden its strategic partnerships and deepen its footprint, expanding its offerings to more at-home diagnostics and treatment options later this year across STI, fertility, menopause, and weight care categories.

To learn more about Wisp, please visit www.hellowisp.com.

ABOUT WISP:

Wisp is a women’s health company on a mission to make sexual and reproductive healthcare more inclusive, cost-effective, and accessible. Available in all 50 states, Wisp provides discreet treatments online with a comprehensive selection of products and telehealth services, including prescription medication, OTC prevention, at-home testing and more. Wisp is a growing and profitable company and is majority-owned by WELL Health Technologies Corp. To learn more, please visit hellowisp.com or follow @hellowisp on Facebook, Instagram, TikTok and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241017781553/en/